Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
5(83%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
33%
Ph phase_2
1
17%
Ph not_applicable
2
33%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
2(40.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

6

all time

Status Distribution
Active(5)
Completed(1)

Detailed Status

Recruiting4
Completed1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
5
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (20.0%)
Phase 32 (40.0%)
N/A2 (40.0%)

Trials by Status

completed117%
active_not_recruiting117%
recruiting467%

Recent Activity

5 active trials
Showing 5 of 6
completednot_applicable

Mobile Technologies and Post-stroke Depression

NCT04043052
recruitingphase_3

Investigate the Efficacy of Chemotherapy in Patients With Positive ctDNA After Surgery and Adjuvant Chemotherapy for a Stage III Colorectal Cancer

NCT06197425
recruitingphase_2

Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study

NCT05089227
active_not_recruiting

Eating Disturbances in Patients With Type 1 Diabetes Initiating Insulin Therapy

NCT07151924
recruitingnot_applicable

Post-Stroke Secondary Prevention With Digital Monitoring

NCT06837311
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04043052Not Applicable

Mobile Technologies and Post-stroke Depression

Completed
NCT06197425Phase 3

Investigate the Efficacy of Chemotherapy in Patients With Positive ctDNA After Surgery and Adjuvant Chemotherapy for a Stage III Colorectal Cancer

Recruiting
NCT05089227Phase 2

Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study

Recruiting
NCT07151924

Eating Disturbances in Patients With Type 1 Diabetes Initiating Insulin Therapy

Active Not Recruiting
NCT06837311Not Applicable

Post-Stroke Secondary Prevention With Digital Monitoring

Recruiting
NCT06813976Phase 3

PRODIGE 98 : Randomized, Multicenter Phase 3 Trial of Adjuvant Chemotherapy With Modified FOLFIRINOX Versus Capecitabine or Gemcitabine in Patients With Resected Ampullary Adenocarcinoma

Recruiting

All 6 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
6